Riskpilot← Back to searchSign inGet full accessRosenhillkliniken AB
ABActiveOrg 5591095079Östermalmsvägen 38Hospital activities · NACE 8610Est. 20171 employees
Revenue 2025
SEK 2,7M
+1877% vs 2024
EBITDA margin
73.4%
+1790% vs 2024
Equity ratio
47.9%
Financial strength
Net profit 2025
SEK 1,2M
+1314% vs 2024
| Revenue | SEK 2,7M | +1877% |
| EBITDA | SEK 2M | +1790% |
| Net profit | SEK 1,2M | +1314% |
| Total assets | SEK 2,7M | +1336% |
| Equity | SEK 1,3M | +834% |
| Employees | 1 | — |
Legal name
Rosenhillkliniken AB
Org number
5591095079
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
20 april 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva: - sjukvård bl.a. på konsultbasis - psykosocial hälsa och friskvård - inköp av skog och skogsvård - fastighetsinköp och fastighetsuthyrning och därmed förenlig verksamhet.
Address
Östermalmsvägen 38
Email
zacariasjilke@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 71 | 89 | 103 | 136 | 2 685 |
| Staff expenses | — | −9 | −3 | −4 | −641 |
| EBITDA | 48 | 57 | 75 | 104 | 1 971 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 48 | 57 | 75 | 104 | 1 971 |
| Net financials | — | 0 | 1 | 0 | −1 |
| Profit before tax | 48 | 57 | 76 | 104 | 1 477 |
| Tax | −10 | −12 | −16 | −21 | −305 |
| Net profit | 38 | 45 | 60 | 83 | 1 173 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 184 | 180 | 212 | 191 | 2 739 |
| Equity | 137 | 132 | 118 | 141 | 1 313 |
| Long-term debt | 24 | 36 | 43 | 1 | 0 |
| Short-term debt | 24 | 12 | 51 | 49 | 933 |
| Total debt | 48 | 48 | 95 | 50 | 933 |
EBITDA margin
73.4%
This company
15.8%
Market median
+365% vs market
20212025
Equity ratio
47.9%
This company
38.2%
Market median
+25% vs market
20212025
Return on equity
89.3%
This company
18.4%
Market median
+385% vs market
20212025
Net profit margin
43.7%
This company
8.1%
Market median
+440% vs market
20212025
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20212025
Debt / equity
1.09×
This company
0.62×
Market median
-76% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SK Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Rosenhillkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sonja Katarina Jilke | Deputy Chief Executive Officer | 0 companies |
| Axel Artur Jeremia Peterson Jilke | Deputy Board Member | 0 companies |
| Peter Zacarias Valfrid Jilke | Chairman | 0 companies |